UUKHA-Christmas-logo (1)UUKHA-Christmas-logo (1)UUKHA-Christmas-logo (1)UUKHA-Christmas-logo (1)
  • Home
  • About Us
    • Who We Are
    • Operational Framework
    • Our Team
  • Our Work
    • Directorates
      • Human Resources for Health
        • Training programs
          • SCALE Program
        • Logistical Support
      • Health Investments and Finance
        • Health Investment Opportunities
        • Projects
      • Health Research and Innovation
        • Bridge Program
    • Consortia
  • Membership
    • Become A Member
    • Membership Map
  • Resources
    • Newsletter
    • UUKHA Documents
    • MINISTRY OF HEALTH
    • Health Education England
    • Members
  • WHRI
  • Events & Blogs
    • Blogs
    • Events
  • Opportunities
  • Contact Us
CLINTON HEALTH ACCESS INITIATIVE
November 4, 2022
EMR4DW
November 4, 2022
November 4, 2022

Kampala, Cambridge, Childhood Cancer (KamCamChildCan; KC3): Improving childhood cancer outcomes

Prof Suzanne D Turner and Dr Jackson Orem
University of Cambridge and Uganda Cancer Institute

KC3 is a collaborative project between the department of pathology at the university of Cambridge and the Uganda Cancer Institute (UCI) with the aim to improve the lives of children with Burkitt lymphoma (BL). BL is a cancer of the immune system which when occurring in children in Sub-Saharan Africa (SSA) is driven by Epstein Barr Virus (EBV) infection in malaria endemic regions (endemic BL; eBL) whilst in high income countries (HIC), it can be linked with EBV infection but is not associated with malaria (sporadic BL; sBL). However, anecdotal evidence suggests that as malaria infection is being increasingly controlled, more children in SSA are presenting with disease more consistent with sBL. Regardless, there is a clear disparity in survival rates with children in HIC benefitting from improvements in therapy with overall survival rates now approaching 95%, whilst for children in LMIC, dependent on where they live, survival varies from just 10-60%. The intention of our research is to close this gap, to facilitate kinder and more effective treatments for children regardless of where they live.

In order to achieve this goal, with finding initially from the institutional grant awarded to Cambridge university from the Global Challenges Research Fund, and more recently from the Alborada Trust, we have established a BL research lab at the UCI in Kampala. These capacity building awards have allowed us to purchase equipment and conduct training activities with staff exchanges occurring between Cambridge and Kampala. We have also secured ethical approval to establish and build a biobank of childhood BL tumour tissue. This will allow us to study the unique genetics of eBL at an unprecedented level though analysing the sub-clonal heterogeneity of this malignancy. Banking of blood plasma from the same patients will also enable us to develop non-invasive tests to monitor disease progression and, in time, to facilitate early disease detection.

We have been fortunate enough to have secured further funding to continue this work from both the Little Princess Trust and the Great Ormond Street Hospital charity in the UK. In the former case, we have funding to take us to 2024 and in the latter to 2025 to achieve three main goals:

  1. To improve our understanding of how eBL develops and evolves at a sub-clonal level towards the development of less toxic yet efficacious therapies specifically for this patient population (Great Ormond Street Hospital charity).
  2. To develop non-invasive assays to monitor response to treatment to facilitate early adjustments to the treatment regimen thus improving therapeutic outcomes (Little Princess Trust).
  3. To apply the non-invasive assays to allow the early detection of eBL by working alongside malaria clinics (Little Princess Trust).

 

Our lab and bioresource at the UCI with (left to right) Sylivestor Kadhumbula (lab technician), Ezra Anecho (research facilities manager) and Dr Nixon Niyonzima (director of research)
Interactions with government, policymakers

Our visit with Dr Aceng , Hon. Minister of Health, Uganda (5th from left) with Jackson Orem and Suzanne Turner, KC3 co-leads (6th and 7th)

The new Uganda Cancer Institute build

The new building will house purpose built research labs adjacent to treatment units that will facilitate research activities

 

 

 

 

Share

Related posts

March 29, 2023

Workshop on UKRI/MRC Funding Opportunities


Read more
December 20, 2022

The 4th UUKHA Symposium Report 2022


Read more
November 15, 2022

VIRTUAL SIMULATED PLACEMENT TO DEVELOP LEADERSHIP SKILLS AND DIGITAL LITERACY AMONG EARLY-CAREER NURSES & MIDWIVES


Read more

Reach Us!

Uganda Address

Afri Courts Building, 3rd Floor

Plot 107, Buganda Road

P.O. Box 70665, Kampala, Uganda

UK Address
Health Education England
(Directorate of Global engagement)
3rd Floor|Piccadilly place|Manchester|M13BN

Contact us

Email: info@uukha.org

Tel: ‎+256 200 900289

© 2023 Uganda - UK Health Alliance. All Rights Reserved.